NCT00896077View on ClinicalTrials.gov

Subcutaneous Administration of Lisofylline to Healthy Normal Subjects and Subjects With Type 1 Diabetes

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

May 31, 2009

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions
HealthyType 1 Diabetes
Interventions
DRUG

Lisofylline

Lisofylline via i.v. administration vs Lisofylline vs s.c. administration

Trial Locations (1)

07601

Advanced Biomedical Research, Inc. (ABR), Hackensack

Sponsors
All Listed Sponsors
lead

DiaKine Therapeutics, Inc.

INDUSTRY